Source:http://linkedlifedata.com/resource/pubmed/id/12163268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
25-26
|
pubmed:dateCreated |
2002-8-6
|
pubmed:abstractText |
The antigenic variation of influenza A virus hemagglutinin (HA) and neuraminidase (NA) glycoproteins requires frequent changes in vaccine formulation. The classical method of creating influenza virus seed strains for vaccine production is to generate 6 + 2 reassortants that contain six genes from a high-yield virus, such as A/PR/8/34 (H1N1) and the HA and NA genes of the circulating strains. The techniques currently used are time-consuming because of the selection process required to isolate the reassortant virus. We generated the high-yield virus A/PR/8/34 (H1N1) entirely from eight plasmids. Its growth phenotype in embryonated chicken eggs was equivalent to that of the wild-type virus. By using this DNA-based cotransfection technique, we generated 6 + 2 reassortants that had the antigenic determinants of the influenza virus strains A/New Caledonia/20/99 (H1N1), A/Panama/2007/99 (H3N2), A/teal/HK/W312 (H6N1), and A/quail/HK/G1/97 (H9N2). Our findings demonstrate that the eight-plasmid system allows the rapid and reproducible generation of reassortant influenza A viruses for use in the manufacture of vaccines.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0264-410X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 Elsevier Science Ltd.
|
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3165-70
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12163268-Animals,
pubmed-meshheading:12163268-Antigenic Variation,
pubmed-meshheading:12163268-Birds,
pubmed-meshheading:12163268-Cell Line,
pubmed-meshheading:12163268-Chick Embryo,
pubmed-meshheading:12163268-China,
pubmed-meshheading:12163268-Czechoslovakia,
pubmed-meshheading:12163268-DNA, Recombinant,
pubmed-meshheading:12163268-Dogs,
pubmed-meshheading:12163268-Genes, Viral,
pubmed-meshheading:12163268-Genetic Vectors,
pubmed-meshheading:12163268-Influenza A virus,
pubmed-meshheading:12163268-Influenza Vaccines,
pubmed-meshheading:12163268-New Caledonia,
pubmed-meshheading:12163268-Panama,
pubmed-meshheading:12163268-Phenotype,
pubmed-meshheading:12163268-Reassortant Viruses,
pubmed-meshheading:12163268-Reproducibility of Results,
pubmed-meshheading:12163268-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12163268-Transfection,
pubmed-meshheading:12163268-Virus Cultivation
|
pubmed:year |
2002
|
pubmed:articleTitle |
Eight-plasmid system for rapid generation of influenza virus vaccines.
|
pubmed:affiliation |
Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105-2794, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|